Delivery Order SPE2DB20D2014-SPE2DB24FD14M
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical supply item. The contract has a ceiling value of $3,746.05 and is a firm fixed-price delivery order with a completion date of June 10, 2025. The contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug Corp is the...
- This federal contract award is a Delivery Order valued at $10,882.86 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, with a period of performance through June 16, 2025. The contract is Firm Fixed Price and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTIHANCE 529 MG/ML VIAL 20ML. The contract has a ceiling value of $26,534.00 and a performance period through July 25, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and a ceiling value of $5,730.00. It was awarded by the Defense Logistics Agency (DLA), a defense agency, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. The contract is not set aside and has an ultimate completion date of June 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Multihance 529mg/ml. The delivery order, valued at $5,323.05, has a firm fixed price and an ultimate completion date of March 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,526.36 Firm Fixed Price Delivery Order is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of August 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,293.95 firm fixed-price delivery order is for the supply of MULTIHANCE 529 MG/ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of November 20, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,733.00 firm fixed price delivery order is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $5,792.88 and is a delivery order contract for the supply of a pharmaceutical product, MULTIHANCE 529MG/ML 5S. The contract has a period of performance through March 6, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite...
- This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FD14MDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product. The award has a ceiling value of $1,513.68 and runs through September 26, 2024. There is no set-aside designation indicated for this contract. AmerisourceBergen, through its Corporate Office Division, is the prime contractor for this order. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which is valued up to $999,999,999 and runs through December 2025. The DLA is a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. military and other federal agencies, and this contract supports the healthcare needs of military personnel and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/25/24 |